Under the Microscope: Reassessing the Foundations of Our Medicines

Moderna's Ambitious mRNA Flu Vaccine Hits a Regulatory Snag

A Regulatory Stumble: FDA Puts Brakes on Moderna's Flu Vaccine Hopes

The Prescription Revolution: How Amazon is Reshaping Medicine Delivery

Novo Nordisk Doubles Down: Lawsuit Against Hims & Hers Continues Despite 'Wegovy Pill' Plans Scrapped

Weight-Loss Drug Wars Escalate: Novo Nordisk Sues Hims & Hers Over Compounded Semaglutide

The Weight-Loss Revolution: Telehealth Giant Hims & Hers Dives into the GLP-1 Market

Trump Launches TrumpRx: A Digital Crusade Against Sky-High Drug Prices

The Shifting Sands of US Drug Pricing: Why Big Pharma Investors are on Edge

The Market's Two Minds: Lilly's High-Stakes Game Meets Housing's Quiet Comeback

Pharmalot's Pulse Check: Navigating Pharma's Twists and Turns

Why Ozempic Isn't Denmark's Greenland Bargaining Chip with the US

The Shifting Sands of Pharma: Innovation, Access, and Lingering Questions in Early 2026

The Pharmaceutical Frontier: Navigating Breakthroughs, Billions, and Bitter Debates

The Unsung Heroes of Biotech: How Biological Buffers Are Fueling a $2.39 Billion Revolution

Big Pharma Breaks Silence: Confronting RFK Jr. on Vaccines

The Great Healthcare Comeback: How Clarity on Pricing and Tariffs Stabilized a Shaken Sector

Unpacking the Ambition: Trump's Most-Favored-Nation Drug Pricing Push

A Seismic Shift Brewing? Cannabis Stocks Soar on Trump's Marijuana Rescheduling Hints

Navigating the Complex Currents of Modern Pharmaceuticals

A Collective Sigh of Relief: Eli Lilly Breaks Nine-Day Losing Streak

The 'Skinny Label' Showdown: How a Supreme Court Case Could Redefine Generics and Drug Prices

A Landmark Win for Innovation: Delhi High Court Upholds Novo Nordisk's Semaglutide Patent

Unlocking Affordable Medicine: A Call for Smarter Biosimilar Regulation

A Critical Look: RFK Jr.'s Vaccine Advisory Committee Convenes for Crucial Discussions

The Pharmaceutical Pulse: A Year-End Reflection on Innovation, Politics, and Public Trust in 2025

The Great Unbundling: Why Weight Loss Drug Prices Are Finally Coming Down

Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation

The Fight for Affordable Medicine: Hospitals Take On 340B Program Changes

A Real Shot in the Arm: The UK and US Forge a Groundbreaking Zero-Tariff Deal on Pharmaceuticals

Unpacking the Trump Administration's Bold Move to Cut Drug Costs

The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

Eli Lilly Slashes Zepbound Prices Amid Political Pressure and Trump's Claims

India's Pharma Vision: Charting a Course for Global Leadership

The Market's Daily Pulse: What's Driving These Top Stocks into the Headlines?

Natco Pharma's Latest Earnings: A Closer Look at Resilience Amidst Market Shifts

A Game-Changer? Trump Set to Unveil Sweeping Healthcare Cost Framework

A Call to Conscience: Karnataka Minister's Stern Warning to Pharma Industry

From Humble Beginnings to Mar-a-Lago Splendor: The Billionaire Pharma Titan's Lavish Celebration